Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival.

PubWeight™: 1.80‹?› | Rank: Top 3%

🔗 View Article (PMID 17111394)

Published in J Surg Oncol on December 01, 2006

Authors

Nikolaos Tzanakis1, Maria Gazouli, George Rallis, George Giannopoulos, Ioannis Papaconstantinou, George Theodoropoulos, Emmanouil Pikoulis, Christos Tsigris, Petros Karakitsos, George Peros, Nikolaos Nikiteas

Author Affiliations

1: 4th Surgical Department, Attikon Hospital, University of Athens, Athens, Greece.

Articles citing this

Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100. J Clin Oncol (2008) 5.38

Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Carcinogenesis (2008) 1.01

Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk. J Cancer Res Clin Oncol (2007) 1.01

Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis. Clin Cancer Res (2009) 0.97

Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy. BMC Cancer (2010) 0.93

Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer. J Korean Med Sci (2008) 0.89

The VEGF -634G>C promoter polymorphism is associated with risk of gastric cancer. BMC Gastroenterol (2009) 0.84

Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer. Yonsei Med J (2008) 0.83

Expression of VEGF, EGFR, and IL-6 in gastric adenomas and adenocarcinomas by endoscopic submucosal dissection. Dig Dis Sci (2009) 0.83

The relationship of vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer. BMC Cancer (2013) 0.82

Salivary VEGF: a non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication. Int Arch Med (2009) 0.82

Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis. Oncol Rep (2012) 0.82

The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancer. J Cancer Res Clin Oncol (2007) 0.82

Association of VEGF genetic polymorphisms with the clinical characteristics of non-Hodgkin's lymphoma. J Cancer Res Clin Oncol (2009) 0.81

Prognostic significance of vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer. Int J Clin Oncol (2012) 0.80

Meta-analysis of the association between VEGF-634 G>C and risk of malignancy based on 23 case-control studies. J Cancer Res Clin Oncol (2010) 0.80

Vascular endothelial growth factor +936C/T polymorphism and gastric cancer risk: A meta-analysis. Exp Ther Med (2011) 0.80

Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer. J Exp Clin Cancer Res (2009) 0.78

C936T polymorphism of the VEGF gene in relation to the risk and the clinical and biological characteristics of sporadic colorectal adenocarcinoma. BMC Res Notes (2014) 0.76

Re: vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival by Tzanakis N, Gazouli M, Rallis G, et al. J Surg Oncol (2006) 0.75

Prognostic significance of vascular endothelial growth factor polymorphisms in colorectal cancer patients. World J Gastrointest Oncol (2017) 0.75

Articles by these authors

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol (2010) 5.65

Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet (2008) 5.05

Accurate microRNA target prediction correlates with protein repression levels. BMC Bioinformatics (2009) 3.21

Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog (2011) 2.53

The impact of endograft type on inflammatory response after endovascular treatment of abdominal aortic aneurysm. J Vasc Surg (2013) 2.07

Mycobacterium avium subsp. paratuberculosis, genetic susceptibility to Crohn's disease, and Sardinians: the way ahead. J Clin Microbiol (2005) 1.82

Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nat Genet (2010) 1.72

Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol (2006) 1.68

Asymptomatic cholelithiasis: is cholecystectomy really needed? A critical reappraisal 15 years after the introduction of laparoscopic cholecystectomy. Dig Dis Sci (2007) 1.67

Trauma management in ancient Greece: value of surgical principles through the years. World J Surg (2004) 1.64

Abdominal desmoid tumors. Surg Oncol (2007) 1.62

Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: predictors and clinical implications. Gynecol Oncol (2011) 1.60

Idiopathic sclerosing encapsulating peritonitis (or abdominal cocoon). BMC Surg (2006) 1.56

Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol (2006) 1.52

Percutaneous cholecystostomy without interval cholecystectomy as definitive treatment of acute cholecystitis in elderly and critically ill patients. South Med J (2008) 1.50

miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis. Inflamm Bowel Dis (2015) 1.47

Differential effects of stent-graft fabrics on arterial stiffness in patients undergoing endovascular aneurysm repair. J Endovasc Ther (2014) 1.46

The low prevalence of helicobacter infection in patients with inflammatory bowel disease could be attributed to previous antibiotic treatment. Am J Gastroenterol (2003) 1.45

Prognostic significance of immunohistochemical expression of the angiogenic molecules vascular endothelial growth factor-A, vascular endothelial growth factor receptor-1 and vascular endothelial growth factor receptor-2 in patients with classical Hodgkin lymphoma. Leuk Lymphoma (2013) 1.44

Liver tissue dissection: ultrasonic or RFA energy? World J Surg (2006) 1.43

Severe pulmonary hypertension due to pulmonary alveolar microlithiasis. Int J Cardiol (2006) 1.37

Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol (2005) 1.28

Angiographic embolization for gastroduodenal hemorrhage: safety, efficacy, and predictors of outcome. Arch Surg (2008) 1.28

Inflammatory pseudotumor associated with Mycobacterium tuberculosis infection. Int J Infect Dis (2008) 1.27

Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol (2011) 1.27

Clinical considerations and therapeutic strategy for sigmoid volvulus in the elderly: a study of 33 cases. World J Gastroenterol (2007) 1.27

Expression of microRNAs in patients with pancreatic cancer and its prognostic significance. Pancreas (2013) 1.26

TGF-beta signalling in colon carcinogenesis. Cancer Lett (2011) 1.26

Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis (2012) 1.24

Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer. Hum Pathol (2011) 1.18

Bile duct injuries associated with laparoscopic and open cholecystectomy: an 11-year experience in one institute. Surg Today (2005) 1.18

Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma. Int J Cancer (2010) 1.16

Recent advances and current controversies in the management of DCIS of the breast. Cancer Treat Rev (2008) 1.15

Increasing diagnostic accuracy with a cell block preparation from thin-layer endometrial cytology: a feasibility study. Acta Cytol (2006) 1.14

BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort. Anticancer Res (2008) 1.12

Ischemic colitis: surging waves of update. Tohoku J Exp Med (2009) 1.11

Emergency liver resection for combined biliary and vascular injury following laparoscopic cholecystectomy: case report and review of the literature. South Med J (2007) 1.09

Relationship between Crohn's disease, infection with Mycobacterium avium subspecies paratuberculosis and SLC11A1 gene polymorphisms in Sardinian patients. World J Gastroenterol (2006) 1.09

Orbital abscess: visual loss following extraction of a tooth--case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2005) 1.09

Assessment of JC polyoma virus in colon neoplasms. Dis Colon Rectum (2005) 1.08

Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. Int J Colorectal Dis (2008) 1.07

Peritoneal tuberculosis in pregnancy mimicking advanced ovarian cancer: a plea to avoid hasty, radical and irreversible surgical decisions. Int J Infect Dis (2009) 1.06

Detection of Mycobacterium avium subsp. paratuberculosis in retail cheeses from Greece and the Czech Republic. Appl Environ Microbiol (2005) 1.05

Coexistence of gastrointestinal stromal tumor (GIST) and colorectal adenocarcinoma: A case report. World J Surg Oncol (2007) 1.04

Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease. J Crohns Colitis (2011) 1.04

Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer. Gastric Cancer (2007) 1.03

Laparoscopic gastric plication for the treatment of morbid obesity: a review. Minim Invasive Surg (2012) 1.03

Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog (2009) 1.02

Two-trocar laparoscopic-assisted appendectomy versus conventional laparoscopic appendectomy in patients with acute appendicitis. J Laparoendosc Adv Surg Tech A (2006) 1.02

A review on the role of microRNA in biology, diagnosis, and treatment of pancreatic adenocarcinoma. Pancreas (2012) 1.01

FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk. Int J Colorectal Dis (2012) 1.01

Myoid hamartoma of the breast: a case report and review of the literature. Breast J (2007) 1.01

CYP2E1 and risk of chemically mediated cancers. Expert Opin Drug Metab Toxicol (2010) 1.01

γ-H2AX expression detected by immunohistochemistry correlates with prognosis in early operable non-small cell lung cancer. Onco Targets Ther (2012) 1.00

E2F-1 transcription factor immunoexpression is inversely associated with tumor growth in colon adenocarcinomas. Anticancer Res (2004) 1.00

Linking chronic infection and autoimmune diseases: Mycobacterium avium subspecies paratuberculosis, SLC11A1 polymorphisms and type-1 diabetes mellitus. PLoS One (2009) 0.99

Synchronous gastric adenocarcinoma and gastrointestinal stromal tumor (GIST) of the stomach: a case report. World J Surg Oncol (2011) 0.99

Distant solitary skeletal muscle metastasis from papillary thyroid carcinoma. Int Surg (2007) 0.99

Celiac artery stenosis: an underappreciated and unpleasant surprise in patients undergoing pancreaticoduodenectomy. J Am Coll Surg (2007) 0.98

Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas. J Pathol (2002) 0.98

Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. Int J Cancer (2005) 0.97

Facial trauma in the Trojan War. Oral Maxillofac Surg (2014) 0.96

Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis. Int J Colorectal Dis (2011) 0.96

Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma. Anticancer Res (2007) 0.96

Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Dig Liver Dis (2012) 0.95